DCE-MRI Using Dotarem® in Evaluation of Therapeutic Response to Sorafenib in Patients With Advanced Stage HCC
Status:
Terminated
Trial end date:
2015-10-12
Target enrollment:
Participant gender:
Summary
The main objective is to evaluate the value of dynamic contrast-enhanced Magnetic Resonance
Imaging (DCE-MRI) in prediction of response of patients with hepatocellular carcinoma (HCC)
to treatment with Sorafenib assessed by mRECIST.